Andrew L Feldman MD

PubMed

• Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin.
  Geffen Kleinstern, Dennis P Robinson, Lisa M Rimsza, Melissa C Larson, Rebecca L King
  Cancer Epidemiology, Biomarkers & Prevention. 2025-03-06
• Hypofractionated Radiation Therapy for Subcutaneous Rosai-Dorfman Disease: A Case Report.
  Rachael M Guenzel, William G Breen, Ronald S Go, Andrew L Feldman, Scott C Lester
  Advances in Radiation Oncology. 2025-03-01
• Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach.
  Catalina Amador, Dennis D Weisenburger, Ana Gomez, Alyssa Bouska, Ahmad Alshomrani
  Modern Pathology. 2025-02-01

Journal Articles

• Publisher Correction: Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes  
  Thomas M Habermann, Scott J Rodig, Rameen Beroukhim, Jeremiah A Wala, Andrew L Feldman, Todd R Golub, Margaret A Shipp, Nature

Abstracts/Posters

• Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018